Join
Live feed
·
INSIDERFilingvia Quantisnow
Merrimack Pharmaceuticals Inc. logo

SEC Form 4: Andersen Eric bought $651,857 worth of Common Stock (100,214 units at $6.50) and sold $338,120 worth of Common Stock (52,914 units at $6.39) (Amendment)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MACK (Merrimack Pharmaceuticals Inc.) and more on Quantisnow.